Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression

Psychopharmacology

Volumn 114, Issue 2, 1994, Pages 309-314

  Papp, Mariusz ^a   Klimek, Violetta ^a   Willner, Paul ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

5HT1A receptors; 5HT2 receptors; Animal model of depression; Beta receptors; Imipramine; Rats; Receptor bind; Stress

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPRENOLOL; BETA ADRENERGIC RECEPTOR; DIHYDROALPRENOLOL; IMIPRAMINE; KETANSERIN; METHYSERGIDE; RADIOLIGAND; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STRESS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMAL; BEHAVIOR, ANIMAL; DEPRESSION; DIHYDROALPRENOLOL; IMIPRAMINE; KETANSERIN; KINETICS; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 0028356097     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244853     Document Type: Article

References (62)

1. Increase in the Bmax of 5-HT-1A receptor following chronic administration of mianserin in an animal model of depression
2. Effect of IAP and chronic antidepressant administration on the 5HT1A receptor in rat cortical membranes
3. Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression
4. Open trial of gepirone in the treatment of major depressive disorder
5. Autoradiographic demonstration of increased serotonin 5HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims
6. Serotonergic measures in the brains of suicide victims: 5HT2 binding sites in the frontal cortex of suicide victims and control subjects
7. Development of beta-adrenergic subsensitivity by antidepressants
8. Regionally selective increases in beta-adrenegic receptor density in brains of suicide victims
9. Serotonin receptor sensitivity after acute and chronic treatment with mianserin
10. Reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer
11. Brain 5HT2 receptor binding sites in suicide victims
12. 5-HT and mechanisms of defence
13. A neuroendocrine study of 5HT function in depression: Evidence for biological mechanisms of endogenous and psychosocial causation
14. SPECT imaging of serotonin2 receptors in depression
15. Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims
16. Brain beta-adrenoceptor binding sites in depressed suicide victims: Effects of antidepressant treatment
17. Buspirone in the management of major depression: a placebo-controlled comparison
18. Progress in assessing the role of serotonin in the control of food intake
19. 5HT2 receptor characteristics in frontal cortex and 5HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice
20. Pharmacological, biochemical and functional properties of 5-HT1A receptor binding sites labelled by [3H]-8-OH-DPAT in the rat brain
21. Gepirone in the treatment of major depression
22. 5-HT1A receptor responsivity in anxiety disorders and depression
23. [3]-Ketanserin (R 41 486), a selective3H-ligand for serotonin2 receptor binding sites
24. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioural tests and receptor binding in rats
25. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims
26. 5HT receptor binding in post-mortem brain from patients with affective disorder
27. Chronic effects of imipramine and lithium on postsynaptic 5-HT1A and 5-HT1B and on presynaptic 5-HT3 sites in rat brain
28. The importance of timing for the action of alpha1- or beta-agonists: possible relationship with the density of [3H]-prazosin and [3H]-dihydroalprenolol binding sites
29. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behavior in rats
30. Suppression of sucrose drinking by chronic mild unpredictable stress. A methodological analysis
31. Changes in dopamine autoreceptor sensitivity in an animal model of depression
32. Dopaminergic mechanism of imipramine action in an animal model of depression
33. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline
34. No alterations in the 5HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants
35. Brain 5HT2 receptors and suicide
36. Single and combined effects of desipramine and lithium on serotonergic receptor number and second messenger function in rat brain
37. Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus
38. Similar effects of treatment with despramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain
39. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
40. Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress
41. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
42. Clinical effects of 5HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression
43. Reversal of antidepressant action by dopamine antagonists in an animal model of depression
44. Open trial of buspirone in the treatment of major depressive disorder
45. The effects of psychoactive drugs on beta-adrenergic binding sites in rat brain
46. Nucleotide interactions with 5-HT1A binding sites directly labelled by [3H]-8-hydroxy-2-(di-n-propylamino)tetralin ([3H]-8-OH-DPAT)
47. Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan
48. Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine
49. Increased serotonin2 binding sites in frontal cortex of suicide victims
50. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP generating system in limbic forebrain
51. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant treatment
52. The validity of animal models of depression
53. Sensitization to the actions of antidepressant drugs
54. Animal models of depression: an overview
55. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant
56. Changes in mesolimbic dopamine may explain stress-induced anhedonia
57. Why is amitriptyline much weaker than desipramine at decreasing beta-adrenoceptor numbers?
58. 5HT2 receptor changes in major depression